Recently, Eris Lifesciences Limited announced the acquisition of the ‘branded Formulation Business’ of Biocon Biologics Limited pertaining to the Indian territory through slump sale. In addition, ELL also announced a foreign acquisition.
Eris Lifesciences Limited (“ELL” or “Eris”) is a publicly listed Indian pharma company and is a leading player in the domestic branded formulations market. Establis...
Already a user? Sign in